Recommended Resource:
MM&M's Pipeline 2007
Medical Marketing & Media, December 2006

What drugs will lead the way in 2007? In this article, Medical Marketing & Media highlights therapeutics and vaccines under development that are generating the most buzz in major categories such as cardiovascular, diabetes, central nervous system, oncology and respiratory. Marketing researchers from both GfK Market Measures and GfK V2 provide their expert opinions on both the therapeutic classes and specific drugs covered in this insightful read.

To download the full article, click the link on the graphic image to the left.





For more insights on these therapeutic areas from the experts included
in the article, please contact the appropriate GfK Market Measures and
GfK V2 consultants listed below:


Rob Delghiaccio, M.B.A.
GfK Market Measures
Associate Vice President & Category Business Leader, Cardiovascular
rdelghiaccio@gfkmarketmeasures.com

Michael Galvin, Ph.D.
GfK V2
Vice President & Oncology Expert
mgalvin@gfkv2.com

Dave Jacobson, Ph.D.
GfK Market Measures
Senior Vice President of the Roper Global Diabetes Management Program djacobson@gfkmarketmeasures.com

Kim Lazarus, M.B.A.
GfK Market Measures
Associate Vice President & Category Business Leader, Neurology & Respiratory
klazarus@gfkmarketmeasures.com

Geoff Penney
GfK Market Measures
Vice President & Category Business Leader, Psychiatry
gpenney@gfkmarketmeasures.com

Noah Pines
GfK V2
Executive Vice President & Viral Diseases Expert
npines@gfkv2.com

Sue Ramspacher, M.A.
GfK Market Measures
Senior Vice President & Category Business Leader, Female Health
sramspacher@gfkmarketmeasures.com

John Taenzler, Ph.D.
GfK V2
Executive Vice President & Autoimmune Disease Expert
jtaenzler@gfkv2.com